Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DANMARKS APOTEKERFORENINGS JUBILÆUMSFOND

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.2% 0.2%   Bankruptcy risk   2.2% 0.8% 0.7% 0.6% 1.6% 0.7% 6.8% 6.6%   Credit score (0-100)   68 93 95 96 74 92 11 12   Credit rating   BBB A A A BBB A BB BB   Credit limit (kDKK)   7.5 14,146.2 15,812.9 16,782.5 302.8 15,912.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   4,858 5,341 5,697 5,698 5,924 6,402 6,402 6,402   Gross profit   4,726 5,227 5,584 5,540 5,813 6,197 0.0 0.0   EBITDA   143 1,909 1,631 2,743 2,409 2,359 0.0 0.0   EBIT   94,831 9,237 9,631 7,940 -3,504 3,602 0.0 0.0   Pre-tax profit (PTP)   94,920.4 9,309.6 9,741.1 7,983.3 -3,469.9 3,839.3 0.0 0.0   Net earnings   74,044.8 7,268.9 7,601.8 6,228.0 -2,697.3 2,999.4 0.0 0.0   Pre-tax profit without non-rec. items   94,920 9,310 9,741 7,983 -3,470 3,839 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   176,100 183,850 191,850 197,250 193,000 194,250 0.0 0.0   Shareholders equity total   145,850 153,119 160,721 166,949 164,251 167,251 159,651 159,651   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   183,715 191,794 200,988 208,532 204,779 209,055 159,651 159,651   Net Debt   -7,193 -7,926 -9,084 -11,269 -11,723 -14,692 -159,651 -159,651     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   4,858 5,341 5,697 5,698 5,924 6,402 6,402 6,402   Net sales growth   7.0% 9.9% 6.7% 0.0% 4.0% 8.1% 0.0% 0.0%   Gross profit   4,726 5,227 5,584 5,540 5,813 6,197 0.0 0.0   Gross profit growth   16.8% 10.6% 6.8% -0.8% 4.9% 6.6% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   183,715 191,794 200,988 208,532 204,779 209,055 159,651 159,651   Balance sheet change%   110.1% 4.4% 4.8% 3.8% -1.8% 2.1% -23.6% 0.0%   Added value   94,831.3 9,236.6 9,631.0 7,940.5 -3,503.5 3,602.5 0.0 0.0   Added value %   1,952.0% 172.9% 169.1% 139.3% -59.1% 56.3% 0.0% 0.0%   Investments   96,100 7,750 8,000 5,400 -4,250 1,250 -194,250 0   Net sales trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   2.9% 35.8% 28.6% 48.1% 40.7% 36.8% 0.0% 0.0%   EBIT %   1,952.0% 172.9% 169.1% 139.3% -59.1% 56.3% 0.0% 0.0%   EBIT to gross profit (%)   2,006.5% 176.7% 172.5% 143.3% -60.3% 58.1% 0.0% 0.0%   Net Earnings %   1,524.1% 136.1% 133.4% 109.3% -45.5% 46.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -424.9% -1.1% -7.0% 18.1% 54.3% 27.4% 0.0% 0.0%   Pre tax profit less extraordinaries %   1,953.8% 174.3% 171.0% 140.1% -58.6% 60.0% 0.0% 0.0%   ROA %   70.0% 5.0% 5.0% 3.9% -1.6% 1.9% 0.0% 0.0%   ROI %   72.4% 5.6% 6.2% 4.9% -2.0% 2.3% 0.0% 0.0%   ROE %   68.0% 4.9% 4.8% 3.8% -1.6% 1.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   67.4% 79.8% 80.0% 80.1% 80.2% 80.0% 100.0% 100.0%   Relative indebtedness %   779.4% 724.1% 706.9% 729.7% 684.1% 653.0% 0.0% 0.0%   Relative net indebtedness %   631.3% 575.7% 547.4% 532.0% 486.2% 423.5% -2,493.7% -2,493.7%   Net int. bear. debt to EBITDA, %   -5,034.8% -415.1% -557.0% -410.8% -486.7% -622.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.5 1.8 2.2 2.6 2.5 2.6 0.0 0.0   Current Ratio   1.5 1.8 2.2 2.6 2.5 2.6 0.0 0.0   Cash and cash equivalent   7,193.3 7,926.5 9,084.3 11,268.9 11,723.4 14,691.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   4,416.6 748.5 851.3 591.2 1,372.3 1,132.5 0.0 0.0   Current assets / Net sales %   156.7% 148.7% 160.4% 198.0% 198.8% 231.3% 2,493.7% 2,493.7%   Net working capital   544.3 1,584.1 2,785.3 4,659.9 4,803.8 6,816.9 0.0 0.0   Net working capital %   11.2% 29.7% 48.9% 81.8% 81.1% 106.5% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0